Skip to main content
Haematology

Low Platelet Count: What Thrombocytopenia Means

A low platelet count (thrombocytopenia) can range from a harmless incidental finding to a sign of serious disease. Understanding the severity and cause is essential — the right blood tests guide the investigation.

What Are Platelets and Why Do They Matter?

Platelets (thrombocytes) are tiny cell fragments produced by megakaryocytes in the bone marrow. Their primary role is haemostasis — forming the initial plug at sites of blood vessel injury to stop bleeding. Each platelet circulates for about 8–10 days before being removed by the spleen. A healthy adult produces approximately 10¹¹ new platelets daily to maintain a normal count.

The normal platelet count in Australian laboratories (RCPA reference range) is 150–400 × 10⁹/L. Thrombocytopenia is defined as a count below 150 × 10⁹/L. However, many people function perfectly well with platelets of 100–150 × 10⁹/L — the critical threshold where spontaneous bleeding becomes a significant risk is generally below 20 × 10⁹/L.

An important first step when a low platelet count is reported is to exclude pseudothrombocytopenia — a laboratory artefact where platelets clump together in the EDTA collection tube, causing the machine to undercount them. A blood film (peripheral smear) can identify this. If clumping is seen, the test should be repeated using a citrate tube.

Severity Classification: When Is It Dangerous?

The risk of bleeding increases as the platelet count falls. The relationship is not linear — most patients have no symptoms above 50 × 10⁹/L, but the risk escalates rapidly below 20 × 10⁹/L. Concurrent use of anticoagulants or NSAIDs (aspirin, ibuprofen) increases bleeding risk at any platelet level.

Mild

100–150 × 10⁹/L

Risk: Minimal bleeding risk

Symptoms: Usually no symptoms. May be discovered incidentally on routine blood tests.

Action: GP review. Repeat FBC in 2–4 weeks. Investigate cause if persistent.

Moderate

50–100 × 10⁹/L

Risk: Low bleeding risk with trauma

Symptoms: Easy bruising, prolonged bleeding from cuts, heavier menstrual periods.

Action: GP review within 1 week. Blood film and further investigation needed.

Severe

20–50 × 10⁹/L

Risk: Significant spontaneous bleeding risk

Symptoms: Petechiae (tiny red/purple dots), spontaneous bruising, nosebleeds, bleeding gums, heavy periods.

Action: Urgent haematology referral. May need treatment. Avoid NSAIDs and contact sports.

Critical

Below 20 × 10⁹/L

Risk: Life-threatening spontaneous haemorrhage risk

Symptoms: Spontaneous mucosal bleeding, large bruises, risk of intracranial haemorrhage.

Action: Emergency (call 000). Hospitalisation likely. May need platelet transfusion or IV immunoglobulin.

5 Major Causes of Low Platelets

Immune Thrombocytopenia (ITP)

Mechanism: Autoimmune destruction — the immune system produces antibodies against platelet surface proteins, causing the spleen to destroy them faster than the bone marrow can replace them. ITP can be primary (no identifiable trigger) or secondary (triggered by infection, medication, or another autoimmune condition).

Primary ITP (most common in adults)
Post-viral ITP (common in children after a cold or flu)
Drug-induced ITP (heparin, quinine, sulfonamides)
Secondary to lupus, HIV, or hepatitis C
FBC + Blood Film
Reticulocyte Count
Anti-platelet Antibodies
HIV, Hepatitis B/C Serology
ANA (if lupus suspected)

Australian context: ITP affects approximately 3–4 per 100,000 adults per year in Australia. In children, it is usually self-limiting after a viral illness. In adults, it tends to be chronic. The RCPA recommends a blood film as the essential first investigation to exclude pseudothrombocytopenia (platelet clumping in the tube, which gives a falsely low count).

Bone Marrow Disorders

Mechanism: Reduced production — the bone marrow fails to produce enough platelets. This can occur when marrow is replaced by cancer cells (leukaemia, lymphoma, myeloma, metastatic cancer), damaged by chemotherapy or radiation, suppressed by severe infections, or affected by myelodysplastic syndromes (MDS) or aplastic anaemia.

Leukaemia and lymphoma
Myelodysplastic syndromes (MDS)
Aplastic anaemia
Chemotherapy or radiation therapy
Metastatic cancer infiltrating bone marrow
FBC + Blood Film
Reticulocyte Count
LDH
Bone Marrow Biopsy (if indicated)
Flow Cytometry

Australian context: Bone marrow disorders are less common causes of isolated thrombocytopenia but must be considered when other cell lines are also affected (low white cells or haemoglobin alongside low platelets — pancytopenia). Haematology referral and bone marrow biopsy are bulk billed under Medicare when clinically indicated.

Liver Disease & Hypersplenism

Mechanism: Sequestration — the spleen normally holds about one-third of circulating platelets. When the liver is damaged (cirrhosis from alcohol, hepatitis, or fatty liver disease), portal hypertension develops, causing the spleen to enlarge (splenomegaly). An enlarged spleen traps and destroys excess platelets. Additionally, the diseased liver produces less thrombopoietin (the hormone that stimulates platelet production).

Alcoholic liver cirrhosis
Chronic hepatitis B or C
Non-alcoholic fatty liver disease (NAFLD)
Portal hypertension from any cause
Liver Function Tests (LFTs)
Hepatitis B/C Serology
Abdominal Ultrasound
FibroScan
Coagulation Studies (INR, APTT)

Australian context: Alcohol-related liver disease is a significant cause of thrombocytopenia in Australia. Approximately 6% of Australian adults drink at levels that increase risk of liver disease. Low platelets may be the first clue to undiagnosed liver disease — the RCPA recommends checking LFTs alongside FBC when thrombocytopenia is identified in patients with alcohol history.

Medications & Infections

Mechanism: Multiple mechanisms — many common medications can lower platelet counts through immune-mediated destruction (heparin-induced thrombocytopenia is the most dangerous), direct bone marrow suppression (chemotherapy, some antibiotics), or increased consumption. Viral infections (dengue, EBV, CMV, HIV) can also cause transient thrombocytopenia through immune activation or direct marrow suppression.

Heparin (HIT — can paradoxically cause clotting)
Valproate, carbamazepine (anti-epileptics)
Trimethoprim-sulfamethoxazole
Proton pump inhibitors (rare)
Dengue fever, EBV (glandular fever), CMV, HIV
Medication Review (critical first step)
FBC trend before and after drug started
HIT antibodies (if on heparin)
Viral serology as indicated
Blood Film

Australian context: Drug-induced thrombocytopenia is often missed because it requires careful timeline correlation. Heparin-induced thrombocytopenia (HIT) is a medical emergency — the platelet count drops 50% or more within 5–10 days of starting heparin, and paradoxically causes clotting, not bleeding. Dengue-related thrombocytopenia is increasingly relevant in northern Australia and among returned travellers.

Pregnancy-Related Thrombocytopenia

Mechanism: Gestational thrombocytopenia is the most common cause of low platelets in pregnancy, accounting for about 75% of cases. It is benign, occurs in the third trimester, and platelets typically stay above 70 × 10⁹/L. However, thrombocytopenia in pregnancy can also signal serious conditions including pre-eclampsia, HELLP syndrome (haemolysis, elevated liver enzymes, low platelets), or gestational ITP, which require urgent obstetric management.

Gestational thrombocytopenia (benign, most common)
Pre-eclampsia / HELLP syndrome
Gestational ITP
Disseminated intravascular coagulation (DIC)
FBC (serial monitoring)
Blood Pressure
Liver Function Tests
Urine Protein
Coagulation Studies
Blood Film

Australian context: Gestational thrombocytopenia affects 5–10% of pregnant women in Australia and is usually harmless. However, any platelet count below 100 × 10⁹/L in pregnancy requires investigation to exclude pre-eclampsia and HELLP syndrome. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) recommends FBC monitoring at each trimester and more frequently if platelets are declining.

What to Ask Your GP

Script for your GP appointment:

“My blood test shows a low platelet count. Could we check a blood film to rule out clumping? I'd also like to understand what might be causing it — could we check my liver function, hepatitis serology, and inflammatory markers?”

Blood film to exclude pseudothrombocytopenia

Repeat FBC in 2–4 weeks (confirm it's real)

Liver function tests (LFTs)

Hepatitis B and C serology

Coagulation studies (INR, APTT)

ANA if autoimmune disease suspected

Thrombocytopenia Blood Test Panel

TestPurposeCost (Australia)
Full Blood Count (FBC)Platelet count, haemoglobin, white cells — the essential starting test
Bulk billed
Blood Film (Peripheral Smear)Visual check for clumping (pseudothrombocytopenia), abnormal cells, fragments
Bulk billed
Reticulocyte CountAssess bone marrow production response
Bulk billed
Liver Function Tests (LFTs)Screen for liver disease causing splenic sequestration
Bulk billed
Coagulation Studies (INR, APTT)Assess overall clotting function alongside platelet count
Bulk billed
Hepatitis B/C, HIV SerologyScreen for viral causes of thrombocytopenia
Bulk billed
ANA, Anti-dsDNAScreen for autoimmune conditions (lupus) if clinically suspected
Bulk billed*
Helicobacter pylori TestH. pylori associated with ITP — eradication can improve platelets
Bulk billed
Bone Marrow BiopsyAssess marrow production when other causes excluded (haematologist)
Bulk billed

* ANA and autoimmune serology are bulk billed when ordered with a clinical indication such as suspected lupus or unexplained persistent thrombocytopenia.


Track Your Platelet Count Over Time

Upload your blood test results and our AI will track platelet trends, flag concerning drops, and help you understand your results — completely free and private.

Reference ranges sourced from the Royal College of Pathologists of Australasia (RCPA). SmarterBlood provides health information and AI-powered blood test analysis. It is not a substitute for professional medical advice, diagnosis, or treatment.



Important: SmarterBlood is an educational health-information service. It is not a medical device, is not a substitute for professional medical advice, diagnosis, or treatment, and does not replace consultation with a qualified healthcare provider. SmarterBlood does not diagnose conditions, prescribe medication, or recommend treatment. Always seek the advice of your doctor or another qualified healthcare provider with any questions you may have regarding a medical condition or your blood test results. Never disregard professional medical advice or delay seeking it because of something you have read on SmarterBlood. SmarterBlood has not been evaluated by the U.S. Food and Drug Administration (FDA), the Therapeutic Goods Administration (TGA), the UK Medicines and Healthcare products Regulatory Agency (MHRA), or Health Canada, and is not intended to diagnose, treat, cure, or prevent any disease.

© 2024-2026 SmarterBlood. All rights reserved.LOINC® codes © Regenstrief Institute